SEP 2022

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/1475139

Contents of this Issue


Page 89 of 90

© 2022 Sight Sciences, Inc. 3/22 TC-2231-US.v1 Indications for Use: The TearCare ® System is intended for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands. The TearCare ® System may not be right for everyone. Please see Instructions for Use or visit TearCare.com for contraindications, warnings, precautions and adverse events. Unobstructed care in your future. Intelligent Heat in Your Expert Hands. Treat DED by targeting obstructive MGD with the TearCare ® System.

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - SEP 2022